Health
BioNTech, Pfizer shares rally on preliminary data showing T-cell response from coronavirus vaccine candidate – MarketWatch
Shares of BioNTech
BNTX,
+3.46%
and Pfizer Inc.
PFE,
+0.69%
both jumped in premarket trading on Monday after the companies said their experimental COVID-19 vaccine produced a T-cell response in people participating in a Phase 1/2 clinical trial in Germany. The vaccine candidate also again demonstrated that it can trigger an antibody response. BioNTech’s stock rallied 10.4% and shares of Pfizer gained 4.1% before the market opened. Analysts and medical experts are paying close attenti…
Continue Reading